When was Vantis Vascular founded?

Vantis Vascular was founded in 2022 and raised its 1st funding round 2 years after it was founded.

Where is Vantis Vascular located?

Vantis Vascular is headquartered in San Jose, United States.

Who is the current CEO of Vantis Vascular?

Jason Turner of Vantis Vascular.

How many employees does Vantis Vascular have?

As of Apr 30, 2026, the latest employee count at Vantis Vascular is 18.

Is Vantis Vascular a funded company?

Vantis Vascular is a funded company, having raised a total of $30M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 21, 2024.

When was the latest funding round of Vantis Vascular?

Vantis Vascular's latest funding was a $***** Grant (prize money) round on Jan 30, 2025, with participation from 1 investor.

Where does Vantis Vascular rank among its competitors?

Vantis Vascular ranks 34th amongst 112 active competitors, of which 45 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Vantis Vascular, which secured $14.3M in Sep, 2024.

Who are the top competitors of Vantis Vascular?

Vantis Vascular's top competitors include TISSIUM, Vivasure Medical and ivWatch. Among them, Vantis Vascular secured the most recent funding round in January, 2025.

Vantis Vascular - 2026 Company Profile, Team, Funding & Competitors

Vantis Vascular is a series B company based in San Jose (United States), founded in 2022. It operates as a Provider of a medical device for vascular interventions. Vantis Vascular has raised $30M in funding. The company has 112 active competitors, including 45 funded and 30 that have exited. Its top competitors include companies like TISSIUM, Vivasure Medical and ivWatch.

Company Details

Provider of a medical device for vascular interventions. It focuses on developing performance driven technology for vascular interventions. It allows the inner microcatheter and outer delivery catheter to one unit when locked, providing pushability to traverse through the most calcific and tortuous anatomies.

Website: vantisvascular.com
Email ID: *****@vantisvascular.com

Key Metrics

Founded Year

2022

Location

San Jose, United States

Stage

Series B

Total Funding

$30M in 4 rounds

Latest Funding Round

Grant (prize money), Jan 30, 2025, $*****

Ranked

34^th among 112 active competitors

Employee Count

18 as on Apr 30, 2026

Similar Companies

TISSIUM & 155 more

View Vantis Vascular's full profile

Vantis Vascular has raised a total funding of $30M over 4 rounds. Its first funding round was on May 21, 2024. Its latest funding round was a Grant (prize money) round on Jan 30, 2025 for $*****. 1 investor participated in its latest round.

Here is the list of recent funding rounds of Vantis Vascular:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 30, 2025	3788480	Grant (prize money)	6061145	8152922	5529768	7334543
Jan 17, 2025	2123646	Grant (prize money)	4828942	2226308	6651269	HHS
Sep 30, 2024	7422259	Series B	2457361	7784254	9337758	3330892

Access funding benchmarks and valuations. Sign up today!

View details of Vantis Vascular's funding rounds and investors

Vantis Vascular's employee count trend

Vantis Vascular has 18 employees as of Apr 26. Here is Vantis Vascular's employee count trend over the years:

Employee count trend for Vantis Vascular

Uncover Vantis Vascular's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Vantis Vascular include TISSIUM, Vivasure Medical and ivWatch. Here is the list of Top 10 competitors of Vantis Vascular, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TISSIUM 2013, Paris (France), Series D	Developer of vascular sealant for open vascular surgery	$156M	Cathay Capital, BNP Paribas Developpement ... & 15 others	65/100
2nd	Vivasure Medical 2009, Galway (Ireland), Acquired	Developer of polymer implants and delivery systems	$92.1M	Fountain Healthcare Partners, Ascent Biomedical Ventures ... & 12 others	61/100
3rd	ivWatch 2010, Williamsburg (United States), Series E	Detecting Intravenous infiltration	$90.1M	757 Angels	55/100
4th	Avenu Medical 2010, Dana Point (United States), Acquired	An image-guided catheter system used to percutaneously create an arteriovenous (AV) fistula	$36M	-	54/100
5th	Aziyo Biologics 2015, Silver Spring (United States), Public	Developer of regenerative medicine products for various applications	$49.6M	Deerfield, HighCape Capital & 2 others	52/100
6th	Laminate Medical 2012, Rehovot (Israel), Series C	Device to prevent AV Fistula failure by promoting their maturation and patency	$20M	Valiance Asset Management, Haisco Pharmaceutical Group ... & 25 others	51/100
7th	Access Vascular 2015, Bedford (United States), Series C	Developer of hydrogel-based devices to improve venous access	$54.3M	TVM Capital Life Science	50/100
8th	Cardival Medical 2002, Santa Clara (United States), Acquired	Developer of a device for vascular access management	$169M	LKCM, Western Technology Investment & 12 others	49/100
9th	EKOS Corporation 1995, Bothell (United States), Acquired	Developer of a device for thrombolysis to treat pulmonary embolism	$58.8M	Mitsui, Trellis Partners & 17 others	49/100
10th	Phraxis 2008, St. Paul (Canada), Series B	Vascular access device for hemodialysis	$14.4M	-	48/100
34th	Vantis Vascular 2022, San Jose (United States), Series B	Provider of a medical device for vascular interventions	$30M	-	36/100